new glp 1 coming out The FDA approved a GLP-1 pill called Foundayo (orforglipron) for adults with obesity or who are overweight and have weight-related health issues: https://bit.ly/4toaoTl The New - GLP-1 receptor

So far, semaglutide (Wegovy) shows the most significant weight loss among approved GLP-1s: Average weight loss: 15 percent or more of body weight over time Administered once weekly Tirzepatide (Mounjaro), though not a pure GLP-1, has shown even greater weight loss in trials and was approved by the FDA specifically for weight management under the name Zepbound

No foam that does not dissipate

2 Although treatment of asymptomatic gallstone patients is not routinely recommended, current treatment algorithms for symptomatic gallstone patients, by contrast, remain predominantly invasive and are based on surgery

BPC-157: A peptide derived from a stomach protein thats being researched for its potential to support tissue repair and gut health

Assessment of permeability in the BCS report is based on the extent of absorption as determined by absolute bioavailability or mass balance

VRA has served as a consultant for Applied Therapeutics, Duke, Fractyl, Novo Nordisk, Pfizer and Sanofi